Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Ltd has filed a compliance certificate under SEBI Regulation 74(5) for the quarter and year ended 31st March, 2026. This regulation requires depositories to confirm compliance with share dematerialization and transfer procedures. The filing is a routine regulatory requirement and indicates the company follows proper share registry maintenance as mandated by SEBI. No material information about company operations or financials is disclosed in this filing.
This is a standard compliance filing with no direct impact on stock price or shareholder value. It confirms the company maintains proper dematerialization records as required by SEBI regulations.